Gerald, full court press for those milestones! The amount of research being done on MANF is nothing short of astonishing, which is going to pave the way with FDA Orphan indications. The medical world is going to be rocked by the emergence of MANF for ischemia, RP, Wolfram's disease, etc, etc. Any one with any science background can see that the research is meticulous and exhaustive at this level. Yes, we are early stage at this point, but that is why the pps is sub .10. Anyone not loading up at this ridiculous level will be kicking themselves in the very near term. I just keep wondering when some BP is going to start pounding on the door wanting a piece of the action. The longer they wait, the price tag just keeps going up. 2015 looks to be the year that AMBS is going to grasp the attention of the world Medical Community. One of these mornings we are going to get a "bunker buster" PR that will ignite a firestorm. Will it be this quarter? Have a look at JP's milestone list, it sure looks like it! Sleep well my friends. "we have not yet begun to fight" JP Jones
Exciting days ahead!
(0)
(0)
Amarantus Bioscience Holdings (AMBS) Stock Research Links